Genetic predisposition factors and nasopharyngeal carcinoma risk: A review of epidemiological association studies, 2000-2011. Rosetta Stone for NPC: Genetics, viral infection, and other environmental factors.

Seminars in Cancer Biology

Volumn 22, Issue 2, 2012, Pages 107-116

  Hildesheim, Allan ^a   Wang, Cheng Ping ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Epidemiology; Genetics; Nasopharyngeal carcinoma; Review

Indexed keywords

ACE GENE; BIRC5 GENE; CANCER RISK; CAV 1 GENE; CELL CYCLE REGULATION; COX 2 GENE; CYP1A1 GENE; CYP2E1 GENE; DLC 1 GENE; DNMT3B GENE; EGF GENE; EGFR GENE; ENVIRONMENTAL FACTOR; ERCC1 GENE; GABBR1 GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE ENVIRONMENT INTERACTION; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HCG9 GENE; HEREDITY; HOGG1 GENE; HUMAN; MDM2 GENE; MMP1 GENE; MMP12 GENE; MMP13 GENE; MMP2 GENE; MMP3 GENE; MMP7 GENE; MMP9 GENE; MOLECULAR DYNAMICS; MPO GENE; MTHFR GENE; N4BP2 GENE; NASOPHARYNX CARCINOMA; NAT2 GENE; NBS1 GENE; NQO1 GENE; ONCOGENE; PLUNC GENE; POLYMERASE CHAIN REACTION; RAD51L1 GENE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TERT GENE; TP53 GENE; VDR GENE; VEGF GENE; XPC GENE; XPD GENE; XRCC1 GENE; XRCC3 GENE;

EPSTEIN-BARR VIRUS INFECTIONS; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84862777830     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2012.01.007     Document Type: Review

References (96)

1. Schottenfeld D., Fraumeni J.F. Cancer epidemiology and prevention 2006, Oxford University Press, Oxford, New York.
2. Chang E.T., Adami H.O. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006, 15:1765-1777.
3. Chung C.C., Chanock S.J. Current status of genome-wide association studies in cancer. Hum Genet 2011, 130:59-78.
4. Chung C.C., Magalhaes W.C., Gonzalez-Bosquet J., Chanock S.J. Genome-wide association studies in cancer - current and future directions. Carcinogenesis 2010, 31:111-120.
5. Varghese J.S., Easton D.F. Genome-wide association studies in common cancers - what have we learnt?. Curr Opin Genet Dev 2010, 20:201-209.
6. Rauch A., Kutalik Z., Descombes P., Cai T., Di Iulio J., Mueller T., et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010, 138:1338-1345. 45 e1-7.
7. Thomas D.L., Thio C.L., Martin M.P., Qi Y., Ge D., O'Huigin C., et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009, 461:798-801.
8. O'Brien T.R. Interferon-alfa, interferon-lambda and hepatitis C. Nat Genet 2009, 41(10):1048-1050.
9. Hildesheim A., Levine P.H. Etiology of nasopharyngeal carcinoma: a review. Epidemiol Rev 1993, 15(2):466-485.
10. Zhou X., Cui J., Macias V., Kajdacsy-Balla A.A., Ye H., Wang J., et al. The progress on genetic analysis of nasopharyngeal carcinoma. Comp Funct Genomics 2007, 57513.
11. Feng B.J., Huang W., Shugart Y.Y., Lee M.K., Zhang F., Xia J.C., et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 2002, 31:395-399.
12. Xiong W., Zeng Z.Y., Xia J.H., Xia K., Shen S.R., Li X.L., et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 2004, 64:1972-1974.
13. Hu L.F., Qiu Q.H., Fu S.M., Sun D., Magnusson K., He B., et al. A genome-wide scan suggests a susceptibility locus on 5p 13 for nasopharyngeal carcinoma. Eur J Hum Genet 2008, 16:343-349.
14. Lu S.J., Day N.E., Degos L., Lepage V., Wang P.C., Chan S.H., et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990, 346:470-471.
15. Li Y., Fu L., Wong A.M., Fan Y.H., Li M.X., Bei J.X., et al. Identification of genes with allelic imbalance on 6p associated with nasopharyngeal carcinoma in southern Chinese. PLoS One 2011, 6:e14562.
16. Dardari R., Khyatti M., Jouhadi H., Benider A., Ettayebi H., Kahlain A., et al. Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma. Int J Cancer 2001, 92:294-297.
17. Makni H., Daoud J., Ben Salah H., Mahfoudh N., Haddar O., Karray H., et al. HLA association with nasopharyngeal carcinoma in southern Tunisia. Mol Biol Rep 2010, 37:2533-2539.
18. Hu S.P., Day N.E., Li D.R., Luben R.N., Cai K.L., Ou-Yang T., et al. Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese. Br J Cancer 2005, 92:967-970.
19. Guo X., Zeng Y., Deng H., Liao J., Zheng Y., Li J., et al. Genetic polymorphisms of CYP2E1, GSTP1, NQO1 and MPO and the risk of nasopharyngeal carcinoma in a Han Chinese population of southern China. BMC Res Notes 2010, 3:212.
20. Jia W.H., Pan Q.H., Qin H.D., Xu Y.F., Shen G.P., Chen L., et al. A case-control and a family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk in Cantonese. Carcinogenesis 2009, 30:2031-2036.
21. Qin H.D., Shugart Y.Y., Bei J.X., Pan Q.H., Chen L., Feng Q.S., et al. Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma. Cancer Res 2011, 71:3000-3008.
22. Sousa H., Pando M., Breda E., Catarino R., Medeiros R. Role of the MDM2 SNP309 polymorphism in the initiation and early age of onset of nasopharyngeal carcinoma. Mol Carcinog 2011, 50:73-79.
23. Xiao M., Zhang L., Zhu X., Huang J., Jiang H., Hu S., et al. Genetic polymorphisms of MDM2 and TP53 genes are associated with risk of nasopharyngeal carcinoma in a Chinese population. BMC Cancer 2010, 10:147.
24. Zhou G., Zhai Y., Cui Y., Zhang X., Dong X., Yang H., et al. MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Clin Cancer Res 2007, 13:2627-2633.
25. Sousa H., Santos A.M., Catarino R., Pinto D., Vasconcelos A., Lopes C., et al. Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development. Eur J Cancer Prev 2006, 15:362-366.
26. Tiwawech D., Srivatanakul P., Karaluk A., Ishida T. The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma. Cancer Lett 2003, 198:69-75.
27. Shao J.Y., Cao Y., Miao X.P., Huang M.Y., Deng L., Hao J.J., et al. A single nucleotide polymorphism in the matrix metalloproteinase 2 promoter is closely associated with high risk of nasopharyngeal carcinoma in Cantonese from southern China. Chin J Cancer 2011, 30:620-626.
28. Zhou G., Zhai Y., Cui Y., Qiu W., Yang H., Zhang X., et al. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma. Hum Mutat 2007, 28:1091-1097.
29. Bei J.X., Li Y., Jia W.H., Feng B.J., Zhou G., Chen L.Z., et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 2010, 42:599-603.
30. Tse K.P., Su W.H., Chang K.P., Tsang N.M., Yu C.J., Tang P., et al. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet 2009, 85:194-203.
31. Ng C.C., Yew P.Y., Puah S.M., Krishnan G., Yap L.F., Teo S.H., et al. A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet 2009, 54:392-397.
32. Tang M., Zeng Y., Poisson A., Marti D., Guan L., Zheng Y., et al. Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population. Genes Immun 2010, 11:334-342.
33. Yu K.J., Gao X., Chen C.J., Yang X.R., Diehl S.R., Goldstein A., et al. Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan. Hum Immunol 2009, 70:910-914.
34. Karanikiotis C., Daniilidis M., Karyotis N., Bakogiannis C., Economopoulos T., Murray S., et al. HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma. Strahlenther Onkol 2008, 184:325-331.
35. Li X., Ghandri N., Piancatelli D., Adams S., Chen D., Robbins F.M., et al. Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians. J Transl Med 2007, 5:22.
36. Butsch Kovacic M., Martin M., Gao X., Fuksenko T., Chen C.J., Cheng Y.J., et al. Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2005, 14:2673-2677.
37. Hildesheim A., Apple R.J., Chen C.J., Wang S.S., Cheng Y.J., Klitz W., et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 2002, 94:1780-1789.
38. Hassen E., Ghedira R., Ghandri N., Farhat K., Gabbouj S., Bouaouina N., et al. Lack of association between human leukocyte antigen-E alleles and nasopharyngeal carcinoma in Tunisians. DNA Cell Biol 2011, 30:603-609.
39. Hirankarn N., Kimkong I., Mutirangura A. HLA-E polymorphism in patients with nasopharyngeal carcinoma. Tissue Antigens 2004, 64:588-592.
40. Ghandri N., Gabbouj S., Farhat K., Bouaouina N., Abdelaziz H., Nouri A., et al. Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome. Hum Immunol 2011, 72:150-158.
41. Jalbout M., Bouaouina N., Gargouri J., Corbex M., Ben Ahmed S., Chouchane L. Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma. Cancer Lett 2003, 193:75-81.
42. Douik H., Ben Chaaben A., Attia Romdhane N., Romdhane H.B., Mamoghli T., Fortier C., et al. Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population. Hum Immunol 2009, 70:45-48.
43. Tian W., Zeng X.M., Li L.X., Jin H.K., Luo Q.Z., Wang F., et al. Gender-specific associations between MICA-STR and nasopharyngeal carcinoma in a southern Chinese Han population. Immunogenetics 2006, 58:113-121.
44. Hassen E., Farhat K., Gabbouj S., Jalbout M., Bouaouina N., Chouchane L. TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population. Cancer Genet Cytogenet 2007, 175:41-46.
45. Sousa H., Breda E., Santos A.M., Catarino R., Pinto D., Medeiros R. Genetic risk markers for nasopharyngeal carcinoma in Portugal: tumor necrosis factor alpha -308G>A polymorphism. DNA Cell Biol 2011, 30:99-103.
46. Yang Z.H., Dai Q., Zhong L., Zhang X., Guo Q.X., Li S.N. Association of IL-1 polymorphisms and IL-1 serum levels with susceptibility to nasopharyngeal carcinoma. Mol Carcinog 2011, 50:208-214.
47. Zhu Y., Xu Y., Wei Y., Liang W., Liao M., Zhang L. Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population. Clin Oncol (R Coll Radiol) 2008, 20:207-211.
48. Wei Y.S., Lan Y., Zhang L., Wang J.C. Association of the interleukin-2 polymorphisms with interleukin-2 serum levels and risk of nasopharyngeal carcinoma. DNA Cell Biol 2010, 29:363-368.
49. Ben Nasr H., Chahed K., Mestiri S., Bouaouina N., Snoussi K., Chouchane L. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma. Hum Immunol 2007, 68:761-769.
50. Wei Y.S., Lan Y., Tang R.G., Xu Q.Q., Huang Y., Nong H.B., et al. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin Immunol 2007, 125:309-317.
51. Farhat K., Hassen E., Gabbouj S., Bouaouina N., Chouchane L. Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma. Int J Immunogenet 2008, 35:197-205.
52. Wei Y.S., Kuang X.H., Zhu Y.H., Liang W.B., Yang Z.H., Tai S.H., et al. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma. Tissue Antigens 2007, 70:12-17.
53. Ben Chaaben A., Busson M., Douik H., Boukouaci W., Mamoghli T., Chaouch L., et al. Association of IL-12p40+1188 A/C polymorphism with nasopharyngeal cancer risk and tumor extension. Tissue Antigens 2011, 78:148-151.
54. Wei Y.S., Lan Y., Luo B., Lu D., Nong H.B. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Mol Carcinog 2009, 48:751-757.
55. Gao L.B., Liang W.B., Xue H., Rao L., Pan X.M., Lv M.L., et al. Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma. Clin Chim Acta 2009, 409:132-135.
56. Nong L.G., Luo B., Zhang L., Nong H.B. Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population. DNA Cell Biol 2009, 28:507-513.
57. Farhat K., Hassen E., Bouzgarrou N., Gabbouj S., Bouaouina N., Chouchane L. Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients. Cytokine 2008, 43:132-137.
58. Wei Y.S., Zhu Y.H., Du B., Yang Z.H., Liang W.B., Lv M.L., et al. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Clin Chim Acta 2007, 380:165-169.
59. Xu Y.F., Liu W.L., Dong J.Q., Liu W.S., Feng Q.S., Chen L.Z., et al. Sequencing of DC-SIGN promoter indicates an association between promoter variation and risk of nasopharyngeal carcinoma in cantonese. BMC Med Genet 2010, 11:161.
60. He J.F., Jia W.H., Fan Q., Zhou X.X., Qin H.D., Shugart Y.Y., et al. Genetic polymorphisms of TLR3 are associated with nasopharyngeal carcinoma risk in Cantonese population. BMC Cancer 2007, 7:194.
61. Song C., Chen L.Z., Zhang R.H., Yu X.J., Zeng Y.X. Functional variant in the 3'-untranslated region of Toll-like receptor 4 is associated with nasopharyngeal carcinoma risk. Cancer Biol Ther 2006, 5:1285-1291.
62. Zhou X.X., Jia W.H., Shen G.P., Qin H.D., Yu X.J., Chen L.Z., et al. Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk. Cancer Epidemiol Biomarkers Prev 2006, 15:862-866.
63. Hirunsatit R., Kongruttanachok N., Shotelersuk K., Supiyaphun P., Voravud N., Sakuntabhai A., et al. Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer. BMC Genet 2003, 4:3.
64. Xiao M., Qi F., Chen X., Luo Z., Zhang L., Zheng C., et al. Functional polymorphism of cytotoxic T-lymphocyte antigen 4 and nasopharyngeal carcinoma susceptibility in a Chinese population. Int J Immunogenet 2010, 37:27-32.
65. Cao Y., Miao X.P., Huang M.Y., Deng L., Lin D.X., Zeng Y.X., et al. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma. Mol Carcinog 2010, 49:944-950.
66. Zhu Q., Wang T., Ren J., Hu K., Liu W., Wu G. FAS-670A/G polymorphism: a biomarker for the metastasis of nasopharyngeal carcinoma in a Chinese population. Clin Chim Acta 2010, 411:179-183.
67. Bel Hadj Jrad B., Mahfouth W., Bouaouina N., Gabbouj S., Ahmed S.B., Ltaief M., et al. A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction. Cancer Lett 2006, 233:21-27.
68. Zhou B., Rao L., Li Y., Gao L., Wang Y., Chen Y., et al. A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Lett 2009, 275:72-76.
69. Cheng Y.J., Chien Y.C., Hildesheim A., Hsu M.M., Chen I.H., Chuang J., et al. No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan. Cancer Epidemiol Biomarkers Prev 2003, 12:179-180.
70. Yang X.R., Diehl S., Pfeiffer R., Chen C.J., Hsu W.L., Dosemeci M., et al. Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in Taiwan. Cancer Epidemiol Biomarkers Prev 2005, 14:900-905.
71. Kongruttanachok N., Sukdikul S., Setavarin S., Kerekhjanarong V., Supiyaphun P., Voravud N., et al. Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study. BMC Cancer 2001, 1:4.
72. He Y., Zhou G.Q., Li X., Dong X.J., Chai X.Q., Yao K.T. Correlation of polymorphism of the coding region of glutathione S-transferase M1 to susceptibility of nasopharyngeal carcinoma in South China population. Ai Zheng 2009, 28:5-7.
73. Guo X., O'Brien S.J., Zeng Y., Nelson G.W., Winkler C.A. GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese. Cancer Epidemiol Biomarkers Prev 2008, 17:1760-1763.
74. Yang Z.H., Dai Q., Kong X.L., Yang W.L., Zhang L. Association of ERCC1 polymorphisms and susceptibility to nasopharyngeal carcinoma. Mol Carcinog 2009, 48:196-201.
75. Zheng J., Zhang C., Jiang L., You Y., Liu Y., Lu J., et al. Functional NBS1 polymorphism is associated with occurrence and advanced disease status of nasopharyngeal carcinoma. Mol Carcinog 2011, 50:689-696.
76. Cho E.Y., Hildesheim A., Chen C.J., Hsu M.M., Chen I.H., Mittl B.F., et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev 2003, 12:1100-1104.
77. Laantri N., Jalbout M., Khyatti M., Ayoub W.B., Dahmoul S., Ayad M., et al. XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countries. Mol Carcinog 2011, 50:732-737.
78. Yang Z.H., Liang W.B., Jia J., Wei Y.S., Zhou B., Zhang L. The xeroderma pigmentosum group C gene polymorphisms and genetic susceptibility of nasopharyngeal carcinoma. Acta Oncol 2008, 47:379-384.
79. Yang Z.H., Du B., Wei Y.S., Zhang J.H., Zhou B., Liang W.B., et al. Genetic polymorphisms of the DNA repair gene and risk of nasopharyngeal carcinoma. DNA Cell Biol 2007, 26:491-496.
80. Cao Y., Miao X.P., Huang M.Y., Deng L., Hu L.F., Ernberg I., et al. Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer 2006, 6:167.
81. Ma F., Zhang H., Zhai Y., Huang W., Zhao C., Ou S., et al. Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese. PLoS One 2011, 6:e16748.
82. Ben Nasr H., Hamrita B., Batbout M., Gabbouj S., Bouaouina N., Chouchane L., et al. A single nucleotide polymorphism in the E-cadherin gene promoter -160C/A is associated with risk of nasopharyngeal cancer. Clin Chim Acta 2010, 411:1253-1257.
83. Nasr H.B., Mestiri S., Chahed K., Bouaouina N., Gabbouj S., Jalbout M., et al. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. Clin Chim Acta 2007, 384:57-63.
84. Ben Nasr H., Chahed K., Bouaouina N., Chouchane L. PTGS2 (COX-2) -765 G>C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma. Mol Biol Rep 2009, 36(1):193-200.
85. Wang T., Hu K., Ren J., Zhu Q., Wu G., Peng G. Polymorphism of VEGF-2578C/A associated with the risk and aggressiveness of nasopharyngeal carcinoma in a Chinese population. Mol Biol Rep 2010, 37:59-65.
86. Nasr H.B., Chahed K., Bouaouina N., Chouchane L. Functional vascular endothelial growth factor -2578C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression. Clin Chim Acta 2008, 395:124-129.
87. Chang K.P., Hao S.P., Tsang N.M., Chang Y.L., Cheng M.H., Liu C.T., et al. Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: a case-control study. Oncol Rep 2008, 19:217-222.
88. Cao Y., Miao X.P., Huang M.Y., Deng L., Liang X.M., Lin D.X., et al. Polymorphisms of methylenetetrahydrofolate reductase are associated with a high risk of nasopharyngeal carcinoma in a smoking population from Southern China. Mol Carcinog 2010, 49:928-934.
89. Li Z.H., Pan X.M., Han B.W., Han H.B., Zhang Z., Gao L.B. No association between ACE polymorphism and risk of nasopharyngeal carcinoma. J Renin Angiotensin Aldosterone Syst 2011.
90. Tsou Y.A., Tsai C.W., Tsai M.H., Chang W.S., Li F.J., Liu Y.F., et al. Association of caveolin-1 genotypes with nasopharyngeal carcinoma susceptibility in Taiwan. Anticancer Res 2011, 31:3629-3632.
91. Feng X.L., Zhou W., Li H., Fang W.Y., Zhou Y.B., Yao K.T., et al. The DLC-1-29A/T polymorphism is not associated with nasopharyngeal carcinoma risk in Chinese population. Genet Test 2008, 12:345-349.
92. Gao L.B., Wei Y.S., Zhou B., Wang Y.Y., Liang W.B., Li C., et al. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma. Cancer Genet Cytogenet 2008, 185:69-73.
93. Zhang Y., Zhang H., Zhai Y., Wang Z., Ma F., Wang H., et al. A functional tandem-repeats polymorphism in the downstream of TERT is associated with the risk of nasopharyngeal carcinoma in Chinese population. BMC Med 2011, 9:106.
94. Huang X., Cao Z., Zhang Z., Yang Y., Wang J., Fang D. No association between Vitamin D receptor gene polymorphisms and nasopharyngeal carcinoma in a Chinese Han population. Biosci Trends 2011, 5:99-103.
95. Zheng M.Z., Qin H.D., Yu X.J., Zhang R.H., Chen L.Z., Feng Q.S., et al. Haplotype of gene Nedd4 binding protein 2 associated with sporadic nasopharyngeal carcinoma in the Southern Chinese population. J Transl Med. 2007, 5:36.
96. He Y., Zhou G., Zhai Y., Dong X., Lv L., He F., et al. Association of PLUNC gene polymorphisms with susceptibility to nasopharyngeal carcinoma in a Chinese population. J Med Genet. 2005, 42:172-176.